NASUS PHARMA LTD: Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in NASUS PHARMA LTD. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
4
13F filers
Aggregate Value
$3.7M
Across holders
Last Price
—
EOD close
Sector
—
GICS
Quarterly fund activity2 increased0 reduced0 exited
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 898K | $3.1M | 84.2% | 0.0% | Unchanged | +$0 | Q2 2026 |
| Hudson Bay Capital Management LP CIK 0001393825 | Hedge Fund | 135K | $472K | 12.6% | 0.0% | Unchanged | +$0 | Q2 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 22K | $77K | 2.1% | 0.0% | Added | — | Q2 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 12K | $43K | 1.1% | 0.0% | Added | — | Q2 2026 |